Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial https://t.co/ggBWrVBnNN
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
@ShekharGupta @ThePrintIndia
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
RT @FaheemYounus: Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Cont…
Treatment News: In Hong Kong COVID patients were randomized to receive Interferon beta-1b (IFN)+kaletra+ ribavirin. Control group didn’t receive IFN IFN group cleared the virus 5 days faster Antiviral combos may be better than single drugs https://t.co
Visual abstract del #IDJClub de hoy, resumiendo la triple terapia de lopi/rito + interferón + ribavirina. Súper bueno, como siempre. https://t.co/28iGYRYgGy
RT @mangarone23: Looking forward to the discussion tonight. join in the discussion @rebecca_kumar @HannahNamMD @McMasters9 @ScottRobertsMD…
Looking forward to the discussion tonight. join in the discussion @rebecca_kumar @HannahNamMD @McMasters9 @ScottRobertsMD @HeiseLyndsey @Onacracker @SajalTanna @taylorhealdme
RT @AaronRichterman: A study of combination IFN beta, LPV/r and ribavirin versus LPV/r showed an improvement in time to negative nasopharyn…
A study of combination IFN beta, LPV/r and ribavirin versus LPV/r showed an improvement in time to negative nasopharyngeal swab PCR for SARS-CoV-2. This is the first major trial to show a difference in viral shedding https://t.co/jyRClXDCqV https://t.co/k1
Me when I read the article in anticipation of discussion tonight at #IDJClub (and not because it is good) https://t.co/jgA7bLkQ9k
Our last #IDJClub (2 weeks ago on an RCT of remdesivir) set a new best in participation, with 87 participants. Tonight we are discussing the 1st published "positive" trial for COVID19: Triple combination therapy (IFN β-1b, lopinavir/ritonavir, ribavirin)
RT @epocrates: Early triple antiviral therapy shows promise in COVID-19. https://t.co/qEDtIeP0hS https://t.co/TfachRTZ5P
RT @IDJClub: Tonight! https://t.co/yqkj0e9KBF
@EricTopol Some good news. https://t.co/ygYGhp1PVk
RT @IDJClub: Tonight! https://t.co/yqkj0e9KBF
@margareth_rei @Rconstantino Aí está o primeiro multicentrico, randomizado com coquetel de 3 retrovirais. Provavelmente o melhor trabalho q já saiu de todos os quase 40 mil publicados E RIP cloroquina https://t.co/Rwlzi8PNaY com outro coquetel de med
RT @IDJClub: Tonight!
RT @IDJClub: Tonight! https://t.co/yqkj0e9KBF
RT @IDJClub: Tonight! https://t.co/yqkj0e9KBF
Tonight!
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial - The Lancet https://t.co/0bf8WV54bK
Reading for discussion tonight. I'm a fan of combination therapies in theory so let's see how this one worked out in practice #IDJClub
RT @accpchest: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospit…
I think we will have to be more careful about opening up, wearing masks, carrying hand santizer, allowing room between people. first good news on a combo drug therapy: https://t.co/u1MhldwkdN
A drug cocktail based on several #HIV #antivirals and a #MultipleSclerosis drug appears to shorten #COVID19 infections https://t.co/I6UyNZy0lW #Coronavirus #Treatment #Effective https://t.co/wXOsBCAKuN
@tomtan916 単剤より3剤併用抗ウイルス療法(インターフェロンβ-1b、ロピナビル・リトナビル、リバビリン)が回復が早いかも知れません。 https://t.co/AoZkDtPPPO
@Covid19Crusher Have you seen this test from Hong Kong? Respected medical journal and good outcomes from trial. Better than Gilead’s results. https://t.co/EyGl7GFOFK
RT @IDJClub: Tomorrow!
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial https://t.co/q7gusrqqBH
RT @infectotuits: We see you there !!
We see you there !!
RT @IDJClub: Tomorrow!
RT @YAYshamsaldeen: دراسة من🇭🇰على127شخص ليسوا بحالة حرجة تناول💊رايتونافير+لوبينافير(كاليترا)؛ تعافوا خلال8ايام من ظهور الاعراض تناول💊كالي…
This triple-drug therapy trial in Hong Kong seems to be working. -VP Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised. - The Lancet ht
@oatila O que tem de insuficiente nesse estudo? https://t.co/n0LJQT1XcM O número e pacientes é inexpressivo?
RT @IDJClub: Tomorrow!
Se habla mucho de la cloro y la hidroxicloroquina pero mientras tanto, se hacen mucho otros ensayos clínicos. Uno de los más notables (y publicados esta semana en Lancet) es éste: https://t.co/S4Ljb2ku0D
It's another #IDJClub!
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial https://t.co/VL7fYwHbDv
@oatila ai átila, ce viu esse estudo aqui? https://t.co/vovPgp0DSu
Tomorrow!
Three antiviral treatments show efficacy in a study out of Hong Kong https://t.co/yqLjJZBYtl
RT @LCalabreseDO: Use of IFN early may have anti-viral effects without driving inflammation!-Triple combination of interferon beta-1b,lopin…
RT @LuisZuritaG: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hosp…
RT @richardhorton1: Important early new data on combination treatment for mild-moderate COVID-19. Extremely encouraging.
RT @accpchest: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospit…
RT @LCalabreseDO: Use of IFN early may have anti-viral effects without driving inflammation!-Triple combination of interferon beta-1b,lopin…
RT @accpchest: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospit…
ribavirin mentioned in movie. ribavirin here irl. https://t.co/8hE6v6Te1T
RT @LCalabreseDO: Use of IFN early may have anti-viral effects without driving inflammation!-Triple combination of interferon beta-1b,lopin…
@DrArturoInfecto ¿Qué opina de este otro estudio Doctor? Saludos. https://t.co/wQFSJAgUmh
RT @LCalabreseDO: Use of IFN early may have anti-viral effects without driving inflammation!-Triple combination of interferon beta-1b,lopin…
RT @LancetRH_WPac: Triple combination of interferon beta-1b, lopinavir–ritonavir, and #ribavirin in the treatment of patients admitted to h…
RT @LCalabreseDO: Use of IFN early may have anti-viral effects without driving inflammation!-Triple combination of interferon beta-1b,lopin…
Use of IFN early may have anti-viral effects without driving inflammation!-Triple combination of interferon beta-1b,lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
RT @DrAbioye: If you want, you can tell them about the trials of lopinavir-ritonavir and interferon which shortened the time to a negative…
RT @KvngKortez: "Patients were randomly assigned (2:1) to a 14-day combination of lopinavir 400 mg and ritonavir 100 mg every 12 h, ribavir…
RT @GermHunterMD: Good news! @IDJClub is back (biweekly!) & here to help you make sense of the deluge of research on COVID-19. Please joi…
If you want, you can tell them about the trials of lopinavir-ritonavir and interferon which shortened the time to a negative result from 12 to 7 days https://t.co/5q9Vf63H6d or about remdesivir which reduced symptoms from 15 to 11 days
RT @accpchest: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospit…
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial https://t.co/UgmC4bGqPD via @TheLancet #COVID19 #CHESTCritCare https://t.
RT @LuisZuritaG: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hosp…
RT @xf_grely: @philippefroguel @hautsdefrance @UMR1283 @CyrilleVan @sandrine_cabut @gkierzek Les pays d’Asie ont des stratégies qui fonctio…
@philippefroguel @hautsdefrance @UMR1283 @CyrilleVan @sandrine_cabut @gkierzek Les pays d’Asie ont des stratégies qui fonctionnent : Singapour comme c’est décrit dans l’article du monde : https://t.co/l9JgpbCekr et Hong Kong avec l’essai clinique dans le L
RT @LuisZuritaG: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hosp…
RT @LuisZuritaG: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hosp…
RT @LuisZuritaG: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hosp…
RT @LuisZuritaG: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hosp…
RT @LuisZuritaG: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hosp…